A48.4
Brazilian purpuric fever
Clinical Classification Guidelines
Inclusion Terms
- Systemic Hemophilus aegyptius infection
Medical Intelligence & Overview
Brazilian purpuric fever (ICD-10 code A48.4) is a rare but serious bacterial infection that primarily affects children. It is caused by the bacteria *Haemophilus aegyptius*, which leads to widespread inflammation and blood vessel damage. This condition is characterized by high fever, rapid decline in health, and distinctive skin symptoms. Recognized as a systemic infection, it requires prompt medical attention to prevent severe complications or death.
Causes & Symptoms
Clinical Causes: Infection with the bacteria *Haemophilus aegyptius* Close contact with infected individuals or contaminated objects Possible underlying immune system vulnerabilities that may increase susceptibility
Key Symptoms: Sudden high fever Pale or mottled skin Purplish skin patches or bruising (purpura) Severe headache Lethargy or irritability Vomiting Rapid breathing Signs of worsening illness such as low blood pressure or collapse
Diagnostic & Treatment
Diagnosis Path: Diagnosis of Brazilian purpuric fever involves a combination of clinical assessment and laboratory tests. Blood cultures are performed to identify *Haemophilus aegyptius*. Additional tests such as complete blood count (CBC), blood chemistry, and bacterial identification techniques help confirm the diagnosis. Due to its severe progression, early diagnosis is essential for effective management.
Treatment Protocols: Treatment typically involves the use of intravenous antibiotics to eliminate the bacterial infection. Supportive care measures such as fluid management, oxygen therapy, and medications to control fever and pain may be administered. Because of the rapid progression and potential severity of the disease, hospitalization is often required. Close monitoring for complications like sepsis or disseminated intravascular coagulation (DIC) is critical.
Clinical Advice & FAQs
Billing Guidance
Is A48.4 a billable ICD-10 code?
Yes, A48.4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report A48.4?
Clinical documentation must specify the nature of Brazilian purpuric fever and any associated comorbidities for accurate reporting.
Cite this Clinical Reference